Has Musa Zaid, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,372 in general payments to Musa Zaid, MD across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Musa Zaid, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Musa Zaid, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Musa Zaid, MD

Orthopaedic Surgery · Daly City, CANPI 1457732034

Payments from drug & device makers

$10,372in general payments, 2019–2025

Across 39 payments — averaging $265.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$7K
Medical Device Business Services, Inc.$2K
Stryker$1K
Zimmer Biomet$294
Davol Inc.$137
Johnson & Johnson$106

What the payments were for

Travel & lodging$1,56515%
Food & beverage$2,55725%
Education$6,25060%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	8	$6,827
Medical Device Business Services, Inc.	8	$1,738
Stryker	18	$1,270
Zimmer Biomet	2	$294
Davol Inc.	1	$137
Johnson & Johnson(2 entities)	2	$106

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,372 in reported general payments places this provider in the 70th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$332,977

Medicare patients

492

Services billed

3,525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	43	$233
Meloxicam	73	$151
Gabapentin	21	$136
Methylprednisolone	13	$101
Tramadol Hcl	11	$57
Amoxicillin	16	$25

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Daly City

Bradford HackArcadia$18.3M
Robert GorabOrange$14.5M
Kelly VinceLos Angeles$9.6M
Stephen HowellSacramento$9.4M
Thomas CoonRed Bluff$9.2M
Peter NewtonSan Diego$7M
Nirav AminPlacentia$5.8M
Tom NorrisSan Francisco$5.3M
Jay LiebermanLos Angeles$4.8M
Sigurd BervenSan Francisco$4.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →